Alvotech — Cash Flow (NASDAQ:ALVO) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities 312.39 M312.19 M236.84 M50.2 M — Cash from investing activities 63.54 M46.34 M18.87 M104.22 M — Cash from financing activities 424.91 M301.32 M297.31 M270.83 M — Free cash flow 312.39 M312.19 M236.84 M50.2 M —

Haberler

Alvotech: Improving Fundamentals Signal Potential Bottom For This Biosimilar Player (ALVO)

UBS, Alvotech hisse hedefini düşürdü

Barclays, Alvotech’in hisse hedefini onay zamanlaması nedeniyle 4 dolara indirdi

Alvotech hisseleri zorlu yılda 3,42 dolarla 52 haftanın dibini gördü

Alvotech 4Ç 2025 sunumu: FDA engelleri arasında yüzde 21 gelir artışı

Alvotech 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ALVO) 2026-03-19

Alvotech kazancı $0,11 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Royce Smaller-Companies Growth Fund FY 2025: What Worked… And What Didn’t

Alvotech hissesi 3,65 dolara düşerek 52 haftanın dibini gördü

Alvotech stock hits 52-week low at 3.65 USD

Alvotech hissesi 3,89 dolarda 52 haftalık dibe vurdu

Alvotech stock hits 52-week low at 3.89 USD